BioBridge Global Expanding Efforts and Reach into Advanced

San Antonio, Texas, Nov. 02, 2022 (GLOBE NEWSWIRE) — BioBridge Global, a nonprofit healthcare services organization, announced today that, building on the success of GenCure, its wholly owned biomanufacturing subsidiary, it is expanding its services and reach into advanced therapies.

To lead the effort, the organization has named Becky Cap to the role of Senior Vice President, Business Development, BioBridge Global Advanced Therapies.

“This is a natural extension of our organization and mission,” said Martin Landon, Chief Executive Officer of BioBridge Global.  “Our customers pursuing cell and gene therapy breakthroughs have needs that extend beyond just process development and biomanufacturing, and we have capabilities across our enterprise to support and aid those efforts.

“Becky is perfectly positioned to coordinate these cross-enterprise activities and services, and we’ve developed a solid portfolio of offerings and capabilities in this space.”

BioBridge Global integrates donor-to-patient services through its three subsidiaries, South Texas Blood & Tissue, QualTex Laboratories and GenCure, to enable the future of biotherapeutic solutions, including blood, tissue and advanced therapies.

Cap, previously Chief Operating Officer of GenCure, will take on responsibilities from strategy to business development to relationship management in the advanced therapies space.

“When we built our biomanufacturing capability, it was with the intent to round out our service offerings to complete what we call the donor-to-patient continuum,” Cap said.

“BioBridge Global has been taking donor material, processing it, ensuring its safety and putting it back into patients for almost 50 years. Our efforts in advanced therapies are the next phase of our evolution in serving our community.”

She noted that customers have responded well to the range of products and services the organization offers in starting materials, testing, and…